Journal of alternative and complementary medicine最新文献

{"title":"Caring for Caregivers-A New Integrative Care Path for Advanced Lung Cancer Patients and Their Caregivers.","authors":"Heidi McLeod, Adam I Perlman, Manisha G Salinas, Abd Moain Abu Dabrh","doi":"10.1089/acm.2020.0396","DOIUrl":"https://doi.org/10.1089/acm.2020.0396","url":null,"abstract":"","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 5","pages":"377-378"},"PeriodicalIF":2.6,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38911230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Analysis of Movement-Based Mind-Body Interventions to Guide the Implementation of Osteoarthritis Exercise Programs: A Descriptive Review of Randomized Controlled Trials.","authors":"Weijun Zhang,&nbsp;Katie Roster,&nbsp;Ron D Hays,&nbsp;Chenchen Wang","doi":"10.1089/acm.2020.0420","DOIUrl":"https://doi.org/10.1089/acm.2020.0420","url":null,"abstract":"<p><p><b><i>Background:</i></b> Clear and complete reporting of the components of complex interventions is required in clinical trials to ensure that research can be reliably replicated and successfully translated into clinical practice. Movement-based mind-body exercises, such as Tai Chi, <i>qigong</i>, and Yoga (TQY), are considered complex interventions and recommended for individuals with osteoarthritis in the latest guidelines of the American College of Rheumatology. This review analyzes the intervention reporting of randomized controlled trials of TQY to guide the implementation in osteoarthritis exercise programs. <b><i>Methods:</i></b> We searched PubMed, Cochrane Central Register of Controlled Trials, and EMBASE for TQY exercise trials in osteoarthritis between 2000 and 2020. Pairs of researchers independently screened the records, extracted study characteristics, and assessed 19 items on the Consensus on Exercise Reporting Template (CERT) checklist. For each of these items, the numbers of studies that clearly reported the item were calculated. We then identified the items in the studies that are key to delivering home-based exercises for further analysis. <b><i>Results:</i></b> We included 27 publications reporting 22 TQY interventions in the analysis. None of the studies reported sufficient details on all the 19 CERT items. The median completeness of reporting score was 11 and ranged from 6 to 15 of 19. The most frequently incompletely reported items (number reporting and percentage of studies) were \"starting level rule\" (<i>n</i> = 1, 5%) and \"progression rule\" (<i>n</i> = 1, 5%). Other incompletely reported items included \"fidelity or adherence (planned)\" (<i>n</i> = 9, 41%), \"motivations\" (<i>n</i> = 9, 41%), and \"progression description\" (<i>n</i> = 5, 23%). <b><i>Conclusions:</i></b> The content analysis highlights motivational strategies for long-term adherence to home-based exercises, which may help clinicians develop interventions for their patients. Details of TQY exercises interventions for osteoarthritis are incompletely reported in the included studies. The study suggests that improvements in content reporting are especially needed on items related to exercise intensity and program progression decisions, and motivational strategies in future implementation.</p>","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 5","pages":"442-457"},"PeriodicalIF":2.6,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881950/pdf/acm.2020.0420.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38911233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cost-Utility of Group Versus Individual Acupuncture for Cancer-Related Pain Using Quality-Adjusted Life Years in a Noninferiority Trial.","authors":"Devesh V Oberoi,&nbsp;Christopher J Longo,&nbsp;Erica Nicole Reed,&nbsp;Jessa Landmann,&nbsp;Katherine-Ann Laura Piedalue,&nbsp;Linda E Carlson","doi":"10.1089/acm.2020.0386","DOIUrl":"https://doi.org/10.1089/acm.2020.0386","url":null,"abstract":"<p><p><b><i>Introduction:</i></b> Individual acupuncture (AP) is the gold standard method of AP delivery for cancer-related pain; however, costs can be prohibitive. Group AP allows four to six patients to be treated in a single session. This study sought to examine the cost-utility of group AP compared with individual AP from a patient perspective. <b><i>Materials and Methods:</i></b> Effectiveness and cost data from a noninferiority randomized trial of group versus individual AP for cancer-related pain were used. In the trial, 74 patients were randomly assigned to individual or group AP treatments twice per week for 6 weeks. The EuroQol five-dimension five level questionnaire (EQ-5D-5L) was used to assess health-related quality of life, and the EQ-5D Utility Index was used as a composite measure constituted of five domains (mobility, self-care, usual activities, anxiety-depression, and pain-discomfort). Linear mixed models were used to compare the change in EQ-5D-5L states pre-post intervention between the two arms. A cost-utility analysis was performed in terms of the incremental costs per additional quality-adjusted life year (QALY) gained. <b><i>Results:</i></b> Group AP participants experienced more significant relief in the pain-discomfort subscale of the EQ-5D-5L measure compared with individual AP participants (<i>group</i> × <i>time</i>, <i>F</i> = 6.18; <i>p</i> = 0.02). The effect size on pain-discomfort for group AP (<i>d</i> = 0.80) was higher than that of individual AP (<i>d</i> = 0.34). There were no significant differences between the two study arms for other subscales of the EQ-5D-5L over time. QALYs at 6 weeks were slightly higher for group AP (0.020) compared with individual AP (0.007) leading to an incremental QALY gained by the group arm of 0.013, but this difference was not statistically significant (<i>p</i> = 0.07). The cost of delivering AP treatment for the group arm over 6 weeks ($201.25) was nearly half of the individual arm ($400). <b><i>Conclusions:</i></b> Group AP was superior to individual AP in cancer patients. These findings have implications for the use of group AP in low-resource settings and in health care systems where AP for cancer patients is not covered by public health insurance. ClinicalTrials.gov (NCT03641222). Registered July 10, 2018-Retrospectively registered, https://clinicaltrials.gov/ct2/show/study/NCT03641222.</p>","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 5","pages":"390-397"},"PeriodicalIF":2.6,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38913037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pyroluria: Fact or Fiction?","authors":"Benjamin Warren,&nbsp;Jerome Sarris,&nbsp;Roger T Mulder,&nbsp;Julia J Rucklidge","doi":"10.1089/acm.2020.0151","DOIUrl":"https://doi.org/10.1089/acm.2020.0151","url":null,"abstract":"<p><p><b><i>Objective:</i></b> The term \"Mauve factor\" (pyrroluria) dates back to 1958 when Dr. Abram Hoffer defined the condition as elevated levels of pyrroles in the urine, currently called hydroxyhemepyrrolin-2-one (HPL). It was suggested that the raised pyrrole levels lead to depletions in zinc and vitamin B₆, which, in turn, were hypothesized to result in a range of psychiatric disorders, such as schizophrenia, anxiety, and depression. Treatment implications are supplementation with zinc and B₆. This article aimed to review the scientific literature associating pyrroluria with psychiatric symptoms, explore the validity of HPL testing, explore the role of nutrients as treatment options for pyrroluria, and discuss future research directions. <b><i>Methods:</i></b> A PRISMA review was conducted using search results from electronic databases PubMed, MEDLINE, PsycINFO, EMBASE from inception to February 2020 using the following keywords: hydroxyhemepyryrrolin (HPL), kryptopyrrole (KP), mauve factor, pyroluria, pyrroluria, monopyrroles. Article reference lists were also scanned and included where relevant. <b><i>Results:</i></b> Seventy-three articles were identified of which only three studies identified significantly higher HPL levels in a psychiatric population compared with controls, and there were no placebo-controlled treatment trials directed at pyrroluria. The other 13 clinical studies either showed no association or did not provide adequate data to show group differences in HPL levels. Despite an extensive history of practitioners diagnosing and treating a wide variety of mental health conditions associated with pyrroluria as well as <i>clinical</i> observations of elevated HPL being associated with psychiatric disorders, there was no clear research that showed the following: (1) elevated HPL is robustly associated with increased mental health symptoms, (2) elevated HPL in urine is associated with increased urine excretion of zinc and B₆, and (3) high-dose zinc and B₆ are an efficacious treatment for mental health problems associated with elevated HPL. <b><i>Conclusions:</i></b> Elevated HPL is a clinically observed, but poorly researched biomarker with unclear associations with mental disorders. Based on current evidence, HPL testing is not recommended as a screening or treatment tool. Further research is required in the following areas: establishment of which specific clinical populations exhibit elevated HPL, validation of the chemistry and validity of testing, and controlled trials to establish efficacy of high-dose zinc and B₆ as treatment of elevated pyrroles.</p>","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 5","pages":"407-415"},"PeriodicalIF":2.6,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38918922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"<i>Letter to the Editor:</i> Efficacy of Fire Needle Therapy for Patients with Psoriasis.","authors":"Yiu Ming Wong","doi":"10.1089/acm.2021.0022","DOIUrl":"https://doi.org/10.1089/acm.2021.0022","url":null,"abstract":"","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 5","pages":"458"},"PeriodicalIF":2.6,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38921076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors Influencing Preference for Intervention in a Comparative Effectiveness Trial of Mindfulness-Based Cancer Recovery and Tai Chi/<i>Qigong</i> in Cancer Survivors.","authors":"Devesh Oberoi,&nbsp;Andrew McLennan,&nbsp;Katherine-Ann Piedalue,&nbsp;Peter M Wayne,&nbsp;Jennifer M Jones,&nbsp;Linda E Carlson","doi":"10.1089/acm.2020.0400","DOIUrl":"https://doi.org/10.1089/acm.2020.0400","url":null,"abstract":"<p><p><b><i>Introduction:</i></b> An important gap between randomized efficacy research and real-world implementation of complementary therapies is the role of patient preferences in influencing engagement and outcome. Several studies have highlighted the benefits of patient preference on health outcomes, but few have investigated the factors associated with preference for interventions, which may be critical to assure the success of program implementation. The current study sought to explore the factors associated with patient preference in an ongoing randomized preference-based trial of Mindfulness-Based Cancer Recovery (MBCR) versus Tai Chi/<i>qigong</i> (TCQ) (the Mindfulness and Tai Chi/<i>qigong</i> in Cancer Health [MATCH] study). <b><i>Materials and Methods:</i></b> A multi-method study design was used. A subsample of participants were purposely selected from the ongoing MATCH study to have representation from both intervention arms and from both men and women across different age groups. Open-ended, semi-structured qualitative interviews were conducted to explore the factors influencing initial patient preference. Interviews were transcribed verbatim and analyzed by using inductive thematic analysis. The treatment acceptability and preference measure was administered to determine patients' ratings of acceptability and credibility of both preferred and nonpreferred interventions. <b><i>Results:</i></b> A total of 13 participants were interviewed prior to program attendance, with 8 (62%) preferring TCQ and 5 (38%) choosing MBCR. Major themes related to patients' preference for intervention included: (1) expectations about the preferred intervention; (2) knowledge of the intervention; (3) past experiences with the intervention; and (4) self-efficacy. Participants' mean treatment acceptability scores were higher for their preferred program than their nonpreferred program. <b><i>Conclusion:</i></b> Understanding the factors that influence cancer survivors' preference for mind-body interventions can augment health care providers' knowledge of the barriers and facilitators for successful implementation of interventions in clinical settings, as well as help patients make informed treatment decisions and improve satisfaction and outcomes. Clinical trial registration no.: NCT03641222.</p>","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 5","pages":"423-433"},"PeriodicalIF":2.6,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38844269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of Flower Therapy for Anxiety in Overweight or Obese Adults: A Randomized Placebo-Controlled Clinical Trial.","authors":"Suzimar de Fátima Benato Fusco,&nbsp;Ana Paula Pancieri,&nbsp;Stéfanie Cristina Pires Amancio,&nbsp;Daniéliso Renato Fusco,&nbsp;Carlos Roberto Padovani,&nbsp;Marcos Ferreira Minicucci,&nbsp;Wilza Carla Spiri,&nbsp;Eliana Mara Braga","doi":"10.1089/acm.2020.0305","DOIUrl":"https://doi.org/10.1089/acm.2020.0305","url":null,"abstract":"<p><p><b><i>Objective:</i></b> The aim of this study was to compare the efficacy of flower therapy for the treatment of anxiety in overweight or obese adults with that of a placebo. The authors examined improvement in sleep patterns, reduction in binge eating, and change in resting heart rate (RHR). <b><i>Design:</i></b> This was a randomized, double-blind, placebo-controlled clinical trial with a parallel-group design and two arms. <b><i>Setting/Location:</i></b> Clinical Research Unit, Medical School, São Paulo State University, Botucatu, SP, Brazil. <b><i>Subjects:</i></b> The study included 40 participants in the placebo group and 41 in the intervention group. Participants were of both genders, from 20 to 59 years of age, overweight or obese, with moderate to high anxiety. <b><i>Interventions:</i></b> The participants were divided into two random groups: one group was treated with Bach flower remedies (BFR) (bottles containing 30 mL of 30% hydro-brandy solution with two drops each of Impatiens, White Chestnut, Cherry Plum, Chicory, Crab Apple, and Pine), and the other group was given a placebo (same solution without BFR). The patients were instructed to orally ingest the solution by placing four drops directly in the mouth four times a day for 4 weeks. <b><i>Outcome measures</i></b>: The primary outcome was anxiety (State-Trait Anxiety Inventory [STAI]). Secondary outcomes were sleep (Pittsburgh Sleep Quality Index [PSQI]), binge eating (Binge Eating Scale [BES]), and RHR (electrocardiogram). <b><i>Results:</i></b> Multivariate analysis showed significant reductions in scores for the following variables in the intervention group when compared with the placebo group: STAI (β = -0.190; <i>p</i> < 0.001), PSQI (β = -0.160; <i>p</i> = 0.027), BES (β = -0.226; <i>p</i> = 0.001), and RHR (β = -0.07; <i>p</i> = 0.003). <b><i>Conclusions:</i></b> The anxiety symptoms, binge eating, and RHRs of the individuals treated with flower therapy decreased, and their sleep patterns improved when compared with those treated with the placebo. Registered at the Brazilian Registry of Clinical Trials (no. RBR-47-kfxh).</p>","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 5","pages":"416-422"},"PeriodicalIF":2.6,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38910869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What Do Academic Physicians Think of Tai Chi? A Qualitative Study.","authors":"Patricia Huston,&nbsp;Deirdre MacGuigan","doi":"10.1089/acm.2020.0418","DOIUrl":"https://doi.org/10.1089/acm.2020.0418","url":null,"abstract":"<p><p><b><i>Background:</i></b> Although there is extensive evidence from randomized controlled trials (RCTs) that Tai Chi maintains health, prevents injury, and mitigates the effects of a number of chronic diseases, it appears that physicians do not commonly recommend it. The objective of this study was to understand academic physicians' views on Tai Chi and why there is an apparent gap between the evidence on Tai Chi and its application in practice. <b><i>Design:</i></b> A qualitative study was conducted using purposive and snowball sampling and semistructured interviews with 15 academic physicians in 6 countries: Australia, Canada, France, New Zealand, the Netherlands, and the United States. The interviews were recorded and transcribed and then coded and analyzed with NVivo 12 software. <b><i>Results:</i></b> All participants were aware of Tai Chi. More than half had never attended a continuing education event where Tai Chi was mentioned or read a scientific article on it. Most had seen or heard of science-based evidence on it, and a few were well versed in the literature in their area of expertise. Almost three-quarters of physicians interviewed thought Tai Chi <i>could be</i> a therapeutic option; however, when asked how often they recommended Tai Chi, about a third indicated never, about a half said only occasionally, and a few identified it regularly. Three factors-lack of access, lack of both physician and patient awareness, and an anticipated lack of patient receptivity to it-seemed to account for most of the hesitation to recommend it. Some thought Tai Chi may be seen as foreign. All made useful suggestions on how to increase the uptake of Tai Chi, including learning from other physicians and integrating more of the evidence into knowledge products, as well as learning more about Tai Chi in undergraduate and continuing medical education. <b><i>Conclusions:</i></b> This exploratory study found that although all the academic physicians interviewed had heard about Tai Chi, most were unaware of the extent of evidence from RCTs supporting its therapeutic effects. To apply this evidence in their practice, they wanted to learn more about it from other physicians, have better integration of the evidence into medical knowledge products, and know that there was access, and patient receptivity, to Tai Chi classes in the communities where they practiced.</p>","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 5","pages":"434-441"},"PeriodicalIF":2.6,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38911227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Phosphatidylserine for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.","authors":"Alisha Bruton, Joy Nauman, Douglas Hanes, Melissa Gard, Angela Senders","doi":"10.1089/acm.2020.0432","DOIUrl":"10.1089/acm.2020.0432","url":null,"abstract":"<p><p><b><i>Objective:</i></b> To examine the evidence for efficacy of phosphatidylserine for symptoms of attention-deficit/hyperactivity disorder (ADHD) in children. <b><i>Methods:</i></b> Medline, Cochrane Library, and ClinicalTrials.gov were searched from inception through August 2020. Studies of any design that assessed phosphatidylserine supplementation for children aged ≤18 years with a diagnosis of ADHD were included in the systematic review; only randomized clinical trials were included in the meta-analysis. Standardized mean differences and 95% confidence intervals (CIs) were calculated, and the heterogeneity of the studies was estimated using <i>I²</i>. The overall quality of the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation tool. <b><i>Results:</i></b> Four studies met the inclusion criteria for the narrative review (<i>n</i> = 344) and three for the meta-analysis (<i>n</i> = 216). Results of the meta-analysis showed a statistically significant effect of 200-300 mg/day of phosphatidylserine on symptoms of inattention relative to placebo (effect size [ES] 0.36; 95% CI: 0.07 to 0.64; <i>p</i> = 0.01). The effects of phosphatidylserine on overall symptoms of ADHD (ES 0.76; 95% CI: -0.07 to 1.60; <i>p</i> = 0.07) and hyperactivity-impulsivity (ES 0.24; 95% CI: -0.04 to 0.53; <i>p</i> = 0.09) were not statistically significant. <b><i>Conclusions:</i></b> Preliminary evidence suggests that phosphatidylserine may be effective for reducing symptoms of inattention in children with ADHD, although the quality of the evidence is low and additional research in this area is warranted.</p>","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 4","pages":"312-322"},"PeriodicalIF":2.3,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208377/pdf/acm.2020.0432.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9270927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Synopses of Cochrane Reviews from Cochrane Library Issue 12 2020 Through Issue 3 2021.","authors":"L. S. Wieland","doi":"10.1089/acm.2021.0105","DOIUrl":"https://doi.org/10.1089/acm.2021.0105","url":null,"abstract":"Editor’s Note: JACM is proud to commence a new column partnership with L. Susan Wieland, PhD, and the Cochrane Complementary Medicine Field. Dr. Wieland, who is Co-Director of the Field, and JACM Editor-in-Chief Holger Cramer, PhD speak to the value of the Cochrane work in the lead editorial in this issue. The two have a long relationship of collaborating on Cochrane projects. As such, this new columnservesdoublyasanadditionalmeansofdeclaringforwhatDr.CramerisbringingtoJACMsincehisstartinthispositioninJanuaryof this year [WS1]. This set of 10 Cochrane systematic review synopses [WS2] offers strong evidence of Cochrane’s recent work in the JACM space. Wieland includes pieces related to interventions such as vegan diets, CoQ10, intermittent fasting, acupuncture, melatonin and more. A part of the selection speaks also to the integrative field’s overlap with whole health, with abstracts that relate, for instance to walking and smoking cessation. I can comfortably speak for Dr. Cramer and the rest of the JACM team that we are pleased to play this ongoing role in the JohnWeeks,ContributionEditor,SpecialProjectsandCollaborations,JACM(johnweeks-integrator.com)","PeriodicalId":14944,"journal":{"name":"Journal of alternative and complementary medicine","volume":"27 4 1","pages":"287-289"},"PeriodicalIF":2.6,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48831665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}